Nagoya, Japan

Takanobu Takamura

This inventor holds 1 USPTO granted patent. Top assignees: Eisai Company, Limited, Nagoya University. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takanobu Takamura. Retrieved from https://idiyas.com/inventor/takanobu-takamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takanobu Takamura: Innovator in Antiplatelet Research

Introduction

Takanobu Takamura is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiplatelet agents. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Takamura holds a patent for a method of obtaining an antiplatelet effect through a quinone derivative. The patent describes a compound represented by the formula (I), where A is a group of the formula (IV) or (V). The variables X and Y can be hydroxy, methoxy, or hydrogen, and n is an integer ranging from 1 to 5. This invention highlights his commitment to finding effective solutions for cardiovascular health.

Career Highlights

Throughout his career, Takanobu Takamura has worked with prominent organizations, including Eisai Company, Limited and Nagoya University. His roles in these institutions have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Takamura has collaborated with esteemed colleagues such as Takayuki Ozawa and Morimitsu Nishikimi. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Takanobu Takamura's contributions to antiplatelet research exemplify his innovative spirit and dedication to improving health outcomes. His patent and collaborations reflect a commitment to advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…